4.6 Ophthalmological effects 4.6.1 Glaucoma GLP-1R agonists exhibit anti-inflammatory and neuroprotective properties, suggesting they could also be beneficial in neurodegenerative diseases (73)
The "pandemic" increase of GLP-1 receptor agonists use and the time of discontinuation before anesthesia: Something new
It was observed that the treatment of rats on a high-fat diet with exendin-4 resulted in a decrease in the number of osteoclasts and the area of eroded surfaces, while there was an increase in the osteoid area, bone mass, and trabecular bone volume
Further increases to 1.0mg, 1.7mg, and potentially 2.4mg happen at four-week intervals based on tolerance and response
The gap between people who see results in two weeks and people who struggle for months often comes down to preparation
No studies have addressed whether dulaglutide could cross the BBB